Polaryx Therapeutics, Inc. (PLYX) reporting calendar
Polaryx Therapeutics, Inc. files periodic reports with the SEC as PLYX on Nasdaq. Atlas tracks 2 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 15 May 2026
- Reports on record
- 2
Open PLYX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 15 May 2026 | 45 days | 0001213900-26-056973 |
| 10-K | 31 Dec 2025 | 24 Mar 2026 | 83 days | 0001213900-26-033064 |
Source: SEC EDGAR company submissions for CIK 0002075320. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.